← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 10, 2020Last known activity
Apr 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 8 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT06941766CollaboratorPhase 1/Phase 2Apr 15, 2025
- NCT06492785CollaboratorN/AOct 1, 2024
- NCT06288360CollaboratorPhase 2Sep 12, 2024
- NCT06289751CollaboratorPhase 2Sep 3, 2024
- NCT06288373CollaboratorPhase 2/Phase 3Apr 22, 2024
- NCT06020755CollaboratorPhase 2Sep 30, 2023
- NCT06028672CollaboratorN/ASep 12, 2023
- NCT04538885CollaboratorPhase 1Sep 10, 2020
Details
- Last known activity
- Apr 15, 2025